|
|
||||||||
Technical Developments |
1 From the Department of Radiology, Vancouver General Hospital and University of British Columbia, Canada (N.T.); and the Department of Radiology, Osaka University Medical School, 2-2 Yamadaoka, Suita, 565-0871, Japan (N.T., N.M., M.M., T.J., T.K., O.H., S.H., S.Y., H.N.). Received November 3, 1999; revision requested December 10; final revision received March 31, 2000; accepted April 4. Address correspondence to N.T. (e-mail: tomiyama@radiol.med.osaka-u.ac.jp).
| ABSTRACT |
|---|
|
|
|---|
Index terms: Biopsies, technology, 60.126 Computed tomography (CT), guidance, 60.12111, 60.12118 Interventional procedures, technology Lung, biopsy, 60.126 Lung, nodule, 60.314, 60.321 Lung neoplasms, 60.314, 60.321
| INTRODUCTION |
|---|
|
|
|---|
15 mm) were 74% (20 of 27 lesions) and 72%, respectively, a significant difference (P < .05). The purpose of the current study was to assess the accuracy of CT-guided needle biopsy with the use of a respiratory gating device.
| Materials and Methods |
|---|
|
|
|---|
The patients included 11 women and 11 men, with a mean age of 56.2 years (age range, 3374 years). The nodules were 7.015.0 mm in maximum diameter (mean diameter, 12.0 mm ± 2.37 [SD]), and the needle path was 28100 mm (mean length, 54.2 mm ± 20.6) long. Of the 22 patients referred for diagnostic biopsy, 17 had pulmonary nodules and a known previous or concurrent malignancy (breast malignancy in two patients, hepatic malignancy in three, cervical malignancy in two, gastric malignancy in two, metastatic cerebellar malignancy in one, colonic malignancy in one, laryngeal malignancy in one, renal malignancy in one, and pulmonary malignancy in four). Nodules were in the upper lobe (n = 9), middle lobe and lingula (n = 1), or lower lobe (n = 13). Our study did not include apical nodules, since the movement of such nodules with respiration was expected to be minimal. The institutional review boards approved the study, and informed consent was obtained from all patients.
All patients had initially undergone conventional diagnostic CT (HiSpeed Advantage; GE Medical Systems, Milwaukee, Wis) of the thorax, with 7- or 10-mm-collimated and additional thin-section imaging focused on the nodule, with 1-3-mm collimation that was reconstructed by using a high-spatial-frequency algorithm.
All biopsies were performed by using a ProSpeed scanner (GE Yokogawa Medical Systems, Tokyo, Japan). The patient was placed on the CT table in a supine or prone position, depending on the most likely route for biopsy.
The respiratory gating device was composed of a commercially available respiratory monitor (Autospirometer System 7; Minato Medical Science, Osaka, Japan), an original trigger device, an original amplifier, an original switching unit, and an electric light bulb. After an initial training episode, the patients breathed through a mouthpiece that was connected to the respiratory monitor and experienced no difficulty in doing so. The respiratory curve was displayed in real time (Fig 1). The patients functional residual capacity level was recognized during quiet breathing; after that, the operator entered a value of any given desired respired volume greater than the functional residual capacity and activated the trigger device. When the patients inspired air volume from functional residual capacity reached the value, a trigger pulse occurred. An original switching unit controlled an electric light bulb, in accordance with the trigger pulse. Subsequently, the patients were instructed to hold their breath when the light bulb illuminated, and a CT scan for the localization of small nodules was obtained. To confirm the location of the nodule, preliminary scans were obtained at a given inspiratory volume. If nodules were initially localized immediately deep to a rib, additional images for localization were obtained at other inspiratory volumes to reposition the nodules away from the rib (Fig 2). The most suitable inspiratory volume, that is, the volume at which the maximum diameter of the lesion was in the intercostal space and there was no major vessel on the biopsy route, was kept constant during subsequent biopsy procedures.
|
|
|
These data were compared with retrospectively collected data on 13 consecutive CT-guided biopsies of pulmonary nodules smaller than 15 mm without the use of a respiratory gating device that were performed from July 1995 to July 1997. The group of patients who underwent this procedure included nine women and four men, with a mean age of 59.2 years (age range, 46.069.0 years). The nodules were 8.015.0 mm in maximum diameter (mean diameter, 12.2 mm ± 2.3), and the needle path was 30.0130.0 mm (mean length, 56.5 mm ± 26.5) long. Nodules were in the upper lobe (n = 6), middle lobe and lingula (n = 1), or lower lobe (n = 6).
In both series, CT-guided biopsies were performed by a resident or fellow (N.M.) under the direction of a staff radiologist, and sampling was performed when a needle tip was demonstrated within the nodule on CT images. The number of passes and complications was recorded. A coaxial technique was used in four CT-guided needle biopsies in which the respiratory gating device was used and in three in which the device was not used. Cytologic examination was performed in all CT-guided needle biopsies. Core-needle (Super-Core; Manan Medical Products, Northbrook, Ill) biopsy was performed in all CT-guided needle biopsies in which the respiratory gating device was used and in seven in which the device was not used. No patient with a negative biopsy result underwent repeat biopsy.
A positive transthoracic needle biopsy result was considered true-positive if there was surgical confirmation, if biopsy of another site revealed cancer or malignancy with the same cytologic and histologic characteristics, or if the patient had a subsequent clinical course consistent with cancer. A negative result was considered true-negative if there was surgical confirmation, if the lesion subsequently disappeared or decreased in size, or if it remained stable for 15 months or more, as seen on follow-up CT scans or chest radiographs.
Diagnostic accuracy was calculated by comparing cytologic or histologic diagnoses based on biopsy findings with final diagnoses based on surgical histologic findings or clinical course. Sensitivity and specificity were calculated for nodules that proved to be malignant at surgery or during the clinical course. Positive and negative predictive values were calculated for nodules with positive and negative results, respectively. The differences in size, needle path length, and location between nodules that underwent biopsy with or without use of the respiratory gating device were assessed by performing the Mann-Whitney test, and the differences in the accuracy, sensitivity, and specificity of biopsy were analyzed by performing the Fisher exact test. A P value of .05 was considered to indicate a significant difference.
| Results |
|---|
|
|
|---|
There were 15 patients with cancer and seven without, in accordance with the reference standard. One patient with two lesions had cancer and a benign abnormality. CT-guided needle biopsy performed with the use of the respiratory gating device was used to identify 14 patients with a result that was positive for cancer; there were 14 true-positive results, one false-negative result (sensitivity, 93% [14 of 15 lesions]), eight true-negative results, and no false-positive results (specificity, 100% [eight of eight lesions]). The diagnostic accuracy was 96% (22 of 23 lesions). The positive and negative predictive values were 100% (14 of 14 lesions) and 89% (eight of nine lesions), respectively.
The 15 cancers were metastatic renal cell cancer (n = 1), metastatic hepatocellular cancer (n = 1), nonsmall cell cancer (n = 12), or small cell cancer (n = 1). Of these, 13 were surgically proved. Because a preoperative diagnosis of cancer had already been established at CT-guided needle biopsy, only the false-negative finding required the acquisition of a frozen section during surgery. Two patients, with a diagnosis of small cell lung cancer or metastatic hepatocellular cancer at CT-guided needle biopsy, did not have surgical confirmation. In both patients, follow-up radiologic and clinical findings were consistent with cancer. CT-guided needle biopsy findings were benign in all eight true-negative lesions. In two (25%) patients, CT-guided needle biopsy revealed a specific result: hamartoma in one and fibrosis in one.
Postbiopsy pneumothorax occurred in five (22%) of the 23 CT-guided needle biopsies in which the respiratory gating device was used. Pneumothorax occurred after the final pass in three patients and after the first pass in two. The two patients who had pneumothorax after the first pass had no pulmonary symptoms and underwent insertion of a small drainage catheter during the examination because the nodules shifted from the original location. After drainage catheter insertion, repeat biopsy was performed.
There were 11 patients with cancer and two without, according to the reference standard. CT-guided needle biopsy without use of the device identified seven patients with results that were positive for cancer; there were seven true-positive results, four false-negative results (sensitivity, 64% [seven of 11 lesions]), two true-negative results, and no false-positive results (specificity, 100% [two of two lesions]). The diagnostic accuracy was 69% (nine of 13 lesions). The positive and negative predictive values were 100% (seven of seven lesions) and 33% (two of six lesions), respectively. All 11 cancers were nonsmall cell cancers; of these, 10 were surgically proved. One patient was subsequently found to have a metastasis, and radiologic and clinical findings were consistent with cancer. Diagnostic accuracy with use of the respiratory gating device was significantly higher than that without use of the device (P < .05). There was no significant difference in sensitivity and specificity between the two groups.
| Discussion |
|---|
|
|
|---|
Wong et al (9) reported active breathing control to reduce radiation therapy margins for organ motion due to breathing in patients with tumors within the thorax and upper part of the abdomen. The apparatus consisted of two pairs of flow monitors and scissor valves, one each to control the inspiration and expiration paths to and from the patient. The patient breathed through a mouthpiece that displayed the changing lung volume in real time. After the patients breathing pattern became stable, the operator initiated active breathing control at a preselected phase in the breathing cycle. Both valves were then closed to immobilize breathing motion. The main disadvantage of their system is that it is large and cumbersome to use. We modified a respiratory monitor that is readily available on the market and easy to set and operate.
Recently, Westcott and colleagues (10) reported the accuracy of transthoracic needle biopsy diagnosis in pulmonary nodules of 15 mm or less maximum diameter. The overall sensitivity was 93% (40 of 43 lesions); specificity, 100% (21 of 21 lesions); and accuracy, 95% (61 of 64 lesions). Their diagnostic accuracy was comparable with published results in larger lesions (5). They mentioned several reasons for this good result, which included operator experience, perseverance, and repeat performance of biopsy. When they initially obtained a negative biopsy result, they performed repeat biopsy in some patients on the same day and performed repeat biopsy in 10 patients (one patient underwent two repeat biopsies) on a subsequent day. They considered additional passes performed on the same day to be part of the same procedure; thus, it is difficult to compare their results with ours. The other reported sensitivity for the detection of cancer with transthoracic needle biopsy in nodules smaller than 20 mm in diameter is 68%96% (4,5,1115). Our result for CT-guided needle biopsy without use of the respiratory gating device is likely to be worse than those previously reported. This is probably because we adopted a strict nodular size criteriona maximum of less than 15 mm.
CT fluoroscopy-guided biopsy also is performed in patients with small pulmonary nodules to overcome variations in patient breathing by using real-time capability (16,17). During early experience with CT fluoroscopy, biopsy of small (<15 mm) pulmonary nodules with CT fluoroscopy was successful in 82% of 20 cases (18). This result is similar to success rates published previously for conventional CT guidance. Although CT fluoroscopy is a useful targeting technique, it is, to our knowledge, available in only a small number of centers. Furthermore, radiation exposure to the operator may result even if needle holders are used to keep the operators hands out of the primary beam (19).
Our study had several limitations. Many factors, including biopsy technique used, comprehensiveness of sampling, number of passes, and availability of histologic evaluation, were not taken into consideration. Moreover, the improvement in diagnostic yield with our technique was based on comparison with historical data. Although, from a statistical point of view, the comparison ideally should have been made with the standard technique in the same group of patients, we did not believe that this could be ethically justified. The next best thing would have been to have a separate group of patients concurrently undergo CT without use of the gating device. If the time frame and personnel performing biopsy had been the same, there would have been less bias. There apparently was a big difference in sensitivity between the two groups, but it was not significant. However, the most important point in the evaluation of this scheme is the comparison of accuracy in each group. Therefore, the value of our present study is warranted, in our opinion.
In summary, we developed a respiratory gating technique that allows CT-guided needle biopsy of small pulmonary nodules. The technique is useful in patients who are unable to hold their breath at a given respiratory level.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Matsuguma, R. Nakahara, T. Kondo, Y. Kamiyama, K. Mori, and K. Yokoi Risk of Pleural Recurrence After Needle Biopsy in Patients With Resected Early Stage Lung Cancer Ann. Thorac. Surg., December 1, 2005; 80(6): 2026 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Carlson, J. P. Felmlee, C. E. Bender, R. L. Ehman, K. L. Classic, T. L. Hoskin, W. S. Harmsen, and H. H. Hu CT Fluoroscopy-guided Biopsy of the Lung or Upper Abdomen with a Breath-hold Monitoring and Feedback System: A Prospective Randomized Controlled Clinical Trial Radiology, November 1, 2005; 237(2): 701 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Carlson, J. P. Felmlee, C. E. Bender, R. L. Ehman, K. L. Classic, H. H. Hu, and T. L. Hoskin Intermittent-Mode CT Fluoroscopy-guided Biopsy of the Lung or Upper Abdomen with Breath-hold Monitoring and Feedback: System Development and Feasibility Radiology, December 1, 2003; 229(3): 906 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Wallace, S. Krishnamurthy, L. D. Broemeling, S. Gupta, K. Ahrar, F. A. Morello Jr, and M. E. Hicks CT-guided Percutaneous Fine-Needle Aspiration Biopsy of Small (<=1-cm) Pulmonary Lesions Radiology, December 1, 2002; 225(3): 823 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.J. van Klaveren, J.D.F. Habbema, J.H. Pedersen, H.J. de Koning, M. Oudkerk, and H.C. Hoogsteden Lung cancer screening by low-dose spiral computed tomography Eur. Respir. J., November 1, 2001; 18(5): 857 - 866. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |